An enzyme-linked immunosorbent assay for p65 oncofetal protein and its potential as a new marker for cancer risk assessment in rodents and humans.
Mirowski
M
M
University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville 78957.
Hanausek
M
M
Sherman
U
U
Adams
A K
AK
Walaszek
Z
Z
Slaga
T J
TJ
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000097:blood; D002794:Choline / Q000494:pharmacology; D002796:Choline Deficiency / Q000503:physiopathology; D004052:Diethylnitrosamine; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000175:diagnosis*; D015513:Oncogene Proteins / Q000032:analysis* / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D012307:Risk Factors; D012878:Skin Neoplasms / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate
D014408:Biomarkers, Tumor; D015513:Oncogene Proteins; D004052:Diethylnitrosamine; D015127:9,10-Dimethyl-1,2-benzanthracene; D002794:Choline; D013755:Tetradecanoylphorbol Acetate